Clinical management of opioid use disorder

JAMA - Journal of the American Medical Association

Volumn 316, Issue 3, 2016, Pages 338-339

  Dunlap, Beth ^a   Cifu, Adam S ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE PLUS NALOXONE; METHADONE; OPIATE;

DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; EVIDENCE BASED MEDICINE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICATION ASSISTED TREATMENT; META ANALYSIS (TOPIC); OPIATE ADDICTION; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK BENEFIT ANALYSIS; SHORT SURVEY; SYSTEMATIC REVIEW (TOPIC); ADVERSE EFFECTS; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PROCEDURES;

EVIDENCE-BASED MEDICINE; HUMANS; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PRACTICE GUIDELINES AS TOPIC;

EID: 84978971958     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2016.9795     Document Type: Short Survey

References (9)

1. Rudd RA, Aleshire N, Zibbell J.E., Gladden RM. Increases in drug and opioid overdose deaths - United States, 2000-2014. MMWR Morb Mortal Wkly Rep. 2016; 64(50-51):1378-1382.
2. Substance Abuse and Mental Health Services Administration Center for Behavioral Health Statistics and Quality. Behavioral Health Trends in the United States: Results From the 2014 National Survey on Drug Use and Health. Washington, DC: Dept of Health and Human Services; 2015.
3. Rosenblatt RA, Andrilla CH, Catlin M, Larson EH Geographic and specialty distribution of US physicians trained to treat opioid use disorder. Ann Fam Med. 2015; 13(1):23-26.
4. Mattick RP, Breen C, Kimber J., Davoli M. Buprenorphine maintenance vs placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. 2014;(2):CD002207.
5. MacArthur GJ, Minozzi S, Martin N., et al. Opiate substitution treatment and HIV transmission in people who inject drugs. BMJ. 2012; 345(3):e5945-e5945.
6. Wood E, Ahamad K, Djurfors C., et al. A Guideline for the Clinical Management of Opioid Addiction. 2015. http://www.vch.ca/media/Opioid-Addiction-Guideline.pdf. Accessed June 28, 2016.
7. Smyth BP, Barry J, Keenan E., Ducray K. Lapse and relapse following inpatient treatment of opiate dependence. Ir Med J. 2010; 103(6):176-179.
8. Mattick RP, Breen C, Kimber J., Davoli M. Methadone maintenance therapy vs no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev. 2009;(3):CD002209.
9. Lofwall MR, Havens JR Inability to access buprenorphine treatment as a risk factor for using diverted buprenorphine. Drug Alcohol Depend. 2012; 126(3):379-383.